Merit Medical Systems EPS - Earnings per Share 2010-2023 | MMSI

Merit Medical Systems eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Merit Medical Systems Annual EPS
2023 $1.62
2022 $1.29
2021 $0.84
2020 $-0.18
2019 $0.10
2018 $0.78
2017 $0.55
2016 $0.45
2015 $0.53
2014 $0.53
2013 $0.39
2012 $0.46
2011 $0.58
2010 $0.35
2009 $0.63
Merit Medical Systems Quarterly EPS
2023-12-31 $0.47
2023-09-30 $0.44
2023-06-30 $0.35
2023-03-31 $0.36
2022-12-31 $0.57
2022-09-30 $0.27
2022-06-30 $0.27
2022-03-31 $0.18
2021-12-31 $0.35
2021-09-30 $0.21
2021-06-30 $0.09
2021-03-31 $0.19
2020-12-31 $0.27
2020-09-30 $-0.05
2020-06-30 $-0.34
2020-03-31 $-0.06
2019-12-31 $-0.07
2019-09-30 $-0.06
2019-06-30 $0.12
2019-03-31 $0.11
2018-12-31 $0.17
2018-09-30 $0.30
2018-06-30 $0.21
2018-03-31 $0.10
2017-12-31 $0.11
2017-09-30 $-0.07
2017-06-30 $0.19
2017-03-31 $0.32
2016-12-31 $0.17
2016-09-30 $0.02
2016-06-30 $0.16
2016-03-31 $0.10
2015-12-31 $0.13
2015-09-30 $0.11
2015-06-30 $0.17
2015-03-31 $0.12
2014-12-31 $0.19
2014-09-30 $0.18
2014-06-30 $0.09
2014-03-31 $0.07
2013-12-31 $0.15
2013-09-30 $0.13
2013-06-30 $0.09
2013-03-31 $0.02
2012-12-31 $0.01
2012-09-30 $0.17
2012-06-30 $0.14
2012-03-31 $0.14
2011-12-31 $0.11
2011-09-30 $0.11
2011-06-30 $0.18
2011-03-31 $0.18
2010-12-31 $0.12
2010-09-30 $-0.06
2010-06-30 $0.16
2010-03-31 $0.13
2009-12-31 $0.14
2009-09-30 $0.17
2009-06-30 $0.17
2009-03-31 $0.15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.697B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.780B 20.42
Becton Dickinson (BDX) United States $68.110B 19.27
West Pharmaceutical Services (WST) United States $26.529B 47.54
Cardinal Health (CAH) United States $24.242B 13.86
Align Technology (ALGN) United States $20.454B 39.49
Cooper (COO) United States $18.834B 28.50
Labcorp (LH) United States $17.507B 15.07
Henry Schein (HSIC) United States $9.419B 16.70
DENTSPLY SIRONA (XRAY) United States $5.791B 14.99
Patterson (PDCO) United States $2.267B 10.86
CONMED (CNMD) United States $2.192B 19.88
STAAR Surgical (STAA) United States $2.081B 79.91
Atrion (ATRI) United States $0.784B 41.86
Lifevantage (LFVN) United States $0.085B 10.98
Pro-Dex (PDEX) United States $0.064B 32.09
Biolase (BIOL) United States $0.006B 0.00